Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-154-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based on the results of the read across studies, a NOAEL of 1000 mg/kg bw/day from the longer duration combined repeated dose and reproductive and development toxicity study (OECD 422) conducted with mono- and di- C12 PSE, Na+ has been considered further for hazard assessment. This is further supported by a similar NOAEL observed in a longer duration (90-day) repeated dose study available with mono- and di- C12 PSE, K+ in rats.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Guideline compliant read across study
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Study 1:A dose range finding study was conducted to determine the oral repeated dose toxicity of the read across substance, mono- and di- C12 PSE, K+, according to OECD Guideline 407 and EU Method B.7, in compliance with GLP. In this study, 3 male and female Wistar rats each received by gavage 10 mL/kg bw test substance at concentrations of 0 (water), 60, 600 and 1000 mg/kg bw, 7 days per week for a period of 14 days. During the treatment period, the animals were observed precisely each day for signs of toxicity. Body weight and food consumption were measured once weekly. At the conclusion of the treatment period, hematological and clinical biochemistry parameters were analyzed and all animals were sacrificed and subjected to necropsy. The wet weight of a subset of tissues was taken and a set of organs/tissues was preserved. The test substance formulations (test substance suspended in aqua ad injectionem) were prepared freshly on each day of administration. Dose volumes were adjusted individually based on weekly body weight measurement. No mortality occurred in the control or any of the dose groups during the treatment period of this study. Slight to moderate clinical signs (pilo erection and salivation) were observed during the first treatment week in 1/3 female animals of the high dose (HD) group. Besides, there were no considerable test substance-related clinical signs in this study. In 1/3 male animals of the HD group, body weight and food consumption decreased in the first treatment week. As the animal recovered in the second treatment week, it is not considered to be a sign of systemic toxicity but rather a local reaction. Besides, treatment with the test substance did not influence food consumption and body weight gain of male and female animals of this study. Test substance administration had a slight effect on haematological parameters analyzed at the end of the treatment period. In the HD group and in female animals of the mid dose (MD) group, a slight to moderate increase in neutrophils with a concurrent slight decrease in lymphocytes was observed in the differential blood cell count at the end of the treatment period. These findings in the differential white blood cell count were assumed to be related to a piece of gavaging cannula that had been swallowed and had subsequently affected food consumption and body weight development. At the end of the treatment period, a slightly and dose dependent elevated serum level of alkaline phosphatase was found in male and female animals of the MD and HD group when compared to the control group. This was not associated with considerable differences in other serum markers for hepatotoxicity (ALT, ASAT, Chol). No specific test substance-related gross pathological changes were recorded for the male and female animals of this study. In male animals of the HD group prostate gland was slightly reduced and epididymis weight was slightly increased in weight, compared to controls. Based on the results of the read across study, the 14 d NOAEL of the test substance was determined to be 600 mg/kg bw/day (Allingham, 2012).
Study 2:A study was conducted to determine the toxicity to reproduction of the read across substance, mono- C12 PSE, Na+, according to OECD Guideline 422, in compliance with GLP. The test substance was administered at 0 (control group), 250, 500 or 1000 mg/kg bw to male Sprague-Dawley SPF rats for 14 days before mating, through the mating period, and up to 1 day before necropsy (42 days in total) and to female Sprague-Dawley SPF rats for 14 days before mating, through the mating period and the gestation period, up to day 4 of lactation (42 to 45 days in total) to investigate the repeated-dose, reproductive and developmental toxicities. In the 0 and 1000 mg/kg bw groups, a 14-day recovery period was allowed after the 42-day administration period to investigate the reversibility of the toxic changes. Administration of the test substance had no effect on any of the following: general condition, findings on detailed observation of the general condition, results of function tests, grip strength, spontaneous motor activity, body weight, food consumption, results of urinalysis (including water intake), or in the results of hematological or blood chemistry tests. Administration of the test substance had no effect on any of the following: general condition, findings on detailed observation of the general condition, results of function tests, grip strength, spontaneous motor activity, body weight, food consumption, results of urinalysis (including water intake), or in the results of hematological or blood chemistry tests. Changes in the forestomach may be considered to be adverse; however, they are also considered to be a result of local irritation of the (irritant) test item (which is brought directly in contact to the mucosa in a massive amount by gavage application) than a true effect of systemic toxicity. Furthermore, in the light of the absence of a forestomach in humans, observed effects on this tissue are of questionable relevance with reference to the extrapolation of the toxic properties of a test substance in humans. Therefore, based on the results of the read across study, the NOAEL for systemic effects is considered to be 1000 mg/kg bw/day(METI, 2005).
Justification for classification or non-classification
Based on the results of the read across studies, the test substance does not meet the criteria for classification for this endpoint according to CLP (Regulation 1272/2008/EC) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.